Bionime Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 573.33 million compared to TWD 412.59 million a year ago. Net income was TWD 39.25 million compared to TWD 13.24 million a year ago. Basic earnings per share from continuing operations was TWD 0.65 compared to TWD 0.22 a year ago. Diluted earnings per share from continuing operations was TWD 0.64 compared to TWD 0.22 a year ago.
For the six months, sales was TWD 1,048.98 million compared to TWD 876.39 million a year ago. Net income was TWD 53.04 million compared to TWD 25.17 million a year ago. Basic earnings per share from continuing operations was TWD 0.88 compared to TWD 0.42 a year ago. Diluted earnings per share from continuing operations was TWD 0.87 compared to TWD 0.41 a year ago.